Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions, including cancer, experts have said. A leading pharmaceutical firm said it is confident that jabs for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030.
Studies into these vaccinations are also showing "tremendous promise," with some researchers saying 15 years' worth of progress has been "unspooled" in 12 to 18 months thanks to the success of the COVID jab.
Paul Burton, the chief medical officer of pharmaceutical company Moderna, said he believes the firm will be able to offer such treatments for "all sorts of disease areas" in as little as five years.
The firm, which created a leading coronavirus vaccine, is developing cancer vaccines that target different tumour types, the Guardian reported.
Burton said: "We will have that vaccine, it will be highly effective, and it will save many hundreds of thousands if not millions of lives. I think we will be able to offer personalised cancer vaccines against multiple different tumour types to people around the world."
He also said that a single injection could cover multiple respiratory infections — protecting vulnerable people against Covid, flu and respiratory syncytial virus (RSV) — while mRNA therapies could be available for rare diseases for which there are currently no drugs.
mRNA-based therapies work by teaching cells how to make a protein that triggers the body's immune response against disease.
**
The above article has been published from a wire source with minimal modifications to the headline and text.
